Clinical aspects and management of Fibromyalgia syndrome

Annals of the Academy of Medicine Singapore

Volumn 38, Issue 11, 2009, Pages 967-973

  Chong, Yong Yeow ^a   Ng, Beng Yeong ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Aetiology; Fibromyalgia Fibromyositis syndromes; History; Pain syndrome

Indexed keywords

5 HYDROXYTRYPTOPHAN; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CITALOPRAM; DESIPRAMINE; DULOXETINE; FLUOXETINE; FLUVOXAMINE; GABAPENTIN; HUMAN GROWTH HORMONE; MILNACIPRAN; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE AGONIST; PARACETAMOL; PAROXETINE; PRAMIPEXOLE; PRASTERONE; PREGABALIN; SAVELLA; SEDATIVE AGENT; TRAMADOL; UNCLASSIFIED DRUG; VENLAFAXINE;

ACUPUNCTURE; AEROBIC EXERCISE; AGITATION; APPETITE; CLINICAL FEATURE; COGNITIVE THERAPY; CONSTIPATION; DIFFERENTIAL DIAGNOSIS; DIZZINESS; DRUG APPROVAL; DRUG DOSE INCREASE; DRUG MECHANISM; DRUG WITHDRAWAL; FIBROMYALGIA; FOOD AND DRUG ADMINISTRATION; HEADACHE; HUMAN; HYPERHIDROSIS; MASSAGE; NAUSEA; PATHOGENESIS; PATIENT EDUCATION; PHYSIOTHERAPY; PRURITUS; QUALITY OF LIFE; RECOMMENDED DRUG DOSE; REVIEW; SIDE EFFECT; SOMNOLENCE; TREATMENT RESPONSE; UNITED STATES; XEROSTOMIA;

EID: 73249118659     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Nimnuan C, Hotopf M, Wessely S. Medically unexplained symptoms: an epidemiological study in seven specialities. J Psychosom Res 2001;51:361-7.
2. Maiden NL, Hurst NP, Lochhead A, Carson AJ, Sharpe M. Medically unexplained symptoms in patients referred to a specialist rheumatology service: prevalence and associations. Rheumatology (Oxford) 2003;42:108-12.
3. Wolfe F, Rasker JJ. Fibromyalgia. In: Firestein GS, Budd RC, Harris E Jr, et al, editors. Firestein: Kelly's Textbook of Rheumatology. 8th ed. Philadelphia: WB Saunders Company, 2008.
4. Yunus MB. Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum 2007;36:339-56.
5. Aceves-Avilla FJ, Ferrari R, Ramos-Remus C. New insights into culture driven disorders. Best Pract Res Clin Rheumatol 2004;18:155-71.
6. David Bradley. Disease Mongering or Medicalization? Available at: http://www.sciencebase.com/science-blog/disease-mongering-and-medicalization. html. Accessed 11 November 2009.
7. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 1990;33:160-72.
8. Cohen ML, Quintner JL. Fibromyalgia syndrome, a problem of tautology. Lancet 1993;342:906-9.
9. Wolfe F. The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis 1997;56:268-271.
10. Crofford LJ, Clauw DJ. Fibromyalgia: where are we a decade after the American College of Rheumatology classification criteria were developed? Arthritis Rheum 2002;46:1136-8.
11. Gowers WR. Lumbago: its lesions and analogues. BMJ 1904;1:117-21.
12. Yunus MB, Kalyan-Raman UP. Muscle biopsy findings in primary fibromyalgia and other forms of nonarticluar rheumatism. Rheum Dis Clin North Am 1989;15:115-34.
13. Goldenberg D. Smith N. Fibromyalgia, rheumatologists, and the medical literature: a shaky alliance. J Rheumatol 2003;30:151-3.
14. Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ, Goldenberg DL, et al. Health status and disease severity in fibromyalgia: results of a six-center longitudinal study. Arthitis Rheum 1997;40:1571-9.
15. Shir Y, Fitzcharles MA. Should rheumatologists retain ownership of fibromyalgia? J Rheumatol 2009;36:667-70.
16. Griffing GT. Fibromyalgia is not a rheumatology disease anymore. Medscape J Med 2008;10:47.
17. Shleryfer E, Jotkowitz A, Karmon A, Nevzorov R, Cohen H, Buskila D. Accuracy of the diagnosis of fibromyalgia by family physicians: is the pendulum shifting? J Rheumatol 2009;36:170-3.
18. Bennett RM. Confounding features of fibromyalgia syndrome: a current perspective of differential diagnosis. J Rheumatol Suppl 1989;19:58-61
19. Al-Allaf AW, Ottewell L and Pullar T. The prevalence and significance of positive antinuclear antibodies in patients with fibromyalgia syndrome: 2-4 years' follow up. Clin Rheumatol 2002;21:472-7.
20. Yunus MB, Berg BC, Masi AT. Multiphase skeletal scintigraphy in primary fibromyalgia syndrome: a blinded study. J Rheumatol 1989;16:1466-8.
21. Reilly PA, Littlejohn GO. Peripheral arthralgic presentation of fibrositis/fibromyalgia syndrome. J Rheumatol 1992;19:281-3.
22. Caro XJ. Immunofl uroescent studies of skin in primary fibrositis syndrome. Am J Med 1986;81(Supp 3A):43-9.
23. Bonafede RP, Downey DC, Bennett RM. An association of fibromyalgia with primary Sjogren's syndrome: a prospective study of 72 patients. J Rheumatol 1995;22:133-6.
24. Kotter I, Neuscheler D, Gunaydin I, Wernet D, Klein R. Is there a predisposition for the development of autoimmune disease in patients with fibromyalgia? Retrospective analysis with long term follow up. Rheumatol Int 2007;27:1031-9.
25. Marder WD, Meenan RF, Felson DT, Reichlin M, Birnbaum NS, Croft JD, et al. The present and future adequacy of rheumatology manpower: A study of health care needs and physician supply (editorial). Arthritis Rheum 1991;34:1209-17.
26. Wolfe F, Michaud K. Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize RA patients with fibromyalgia. J Rheumatol 2004;31:695-700.
27. Middleton GD, McFarlin JE, Lipsky PE. The prevalence and clinical impart of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum 1994;37:1181-8.
28. Mark Ng CW, Bernard Ng. Fibromyalgia in Singapore. Presented at the 19th Annual Combined Scientific Meeting, Chapter of Physician, Academy of Medicine, Singapore; July 1999 (Published abstract).
29. Arshad A, Kong KO. Awareness and perceptions of fibromyalgia syndrome: a survey of Malaysian and Singaporean rheumatologists. Singapore Med J 2007;48:25-30.
30. Kinder AJ, Dawes PT, Clement D, Hollows C. Do patients with fibromyalgia undergo unnecessary operations? Rheumatology 2004;43(supplement 2):ii72 (Published abstract).
31. Hughes G, Martinez C, Myon E, Taïeb C, Wessely S. The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice. Arthritis Rheum 2006;54:177-83.
32. Annemans L, Wessely S, Spaepen E, Caekelbergh K, Caubère JP, Le Lay K, et al. Health economic consequences related to the diagnosis of fibromyalgia syndrome. Arthritis Rheum 2008;58:895-902.
33. Wolfe F, Ross K, Anderson J, Russell IJ, Herbert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
34. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo R, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008;58:26-35.
35. Buskila D, Press J, Gedalia A, Klein M, Neumann L, Boehm R, et al. Assessment of nonarticular tenderness and prevalence of fibromyalgia in children. J Rheumatol 1993;20:368-70.
36. Buskila D, Neumann L, Hershman E, Gedalia A, Press J, Sukenik S. Fibromyalgia syndrome in children - an outcome study. J Rheumatol 1995;22:525-8.
37. Wolfe F, Cathey MA. Prevalence of primary and secondary fibrositis. J Rheumatol 1983;10:965-8.
38. Yunus MB, Masi AT, Calabro JJ, Miller KA, Feigenbaum SL. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981;11:151-71.
39. Moldofsky H, Scarisbrick P, England R and Smythe H. Musculoskeletal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. Psychosom Med 1975;37:341-51.
40. Moldofsky H, Scarisbrick P. Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom Med 1976;38:35-44.
41. Gracely RH, Petzke F, Wolf JM, Clauw DJ. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002;46:1333-43.
42. Cook DB, Lange G, Ciccone DS, Liu WC, Steffeer J, Natelson BH. Functioning imaging of pain in patients with primary fibromyalgia. J Rheumatol 2004;31:364-78.
43. Gibson SJ, Littlejohn GO, Gorman MM, Helme RD, Granges G. Altered heat pain thresholds and cerebral event-related potentials following painful CO2 laser stimulation in subjects with fibromyalgia syndrome. Pain 1994;58:185-93.
44. Abeles AM, Pillinger MH, Solitar BM, Abeles M. Narrative review: the pathophysiology of fibromyalgia. Ann Intern Med 2007;146:726-34.
45. Clauw DJ, Chrousos GP. Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 1997;4:134-53.
46. Arnold LM, Hudson JI, Keck PE, Auchenbach MB, Javaras KN, Hess EV. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry 2006;67:1219-25.
47. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA 2004;292:2388-95.
48. Carville SF, Arendt-Nielsen S, Bliddal H, Blotman F, Branco JC, Buskila D, et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 2008;67:536-41.
49. Boomershine CS, Crofford LJ. A symptom-based approach to pharmacologic management of fibromyalgia. Nat Rev Rheumatol 2009;5:191-9.
50. Burckhardt CS, Goldenberg D, Crofford LJ, Gerwin R, Gowans S, Jackson K, et al. Fibromyalgia Syndrome Pain Management Guideline Panel 2002-2005. Guideline for the management of fibromyalgia pain in adults and childrens: APTS Clinical Practice 2005 Guideline Series, No 4. Glenview, IL: American Pain Society.
51. Wood PB. Treating comorbidities in fibromyalgia. Pain Pract 2008;18:42-53.
52. Karjalainen KA, Malmivaara A, van Tulder M, Roine R, Jauhiainen M, Hurri H, et al. Multidisciplinary rehabilitation for fibromyalgia and musculoskeletal pain in working age adults. Cochrane Database Syst Rev 2000;2:CD001984.
53. Hauser W, Bernardy K, Arnold B, Offenbacher M, Schiltenwolf M. Efficacy of multicomponent treatment in fibromyalgia syndrome: a meta-analysis of randomized controlled clinical trials. Arthritis Rheum 2009;61:216-24.
54. Rooks DS. Fibromyalgia treatment update. Curr Opin Rheumatol 2007;19:111-7.
55. Arnold LM, Russell IJ, Diri EW, Duan WR, Young JP Jr, Sharma U, et al. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain 2008;9:792-805.
56. Crofford LJ, Rowbotham MC, Mease PJ, Russell IJ, Dworkin RH, Corbin AE, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005;52:1264-127.
57. Mease PJ, Russell IJ, Arnold LM, Florian H, Young JP Jr, Martin SA, et al. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol 2008;4:514-5.
58. Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochcrane Database Syst Rev 2009;(3):CD007076.
59. Arnold LM, Goldenberg, DI, Stanford SB, Lalonde JK, Sandhu HS, Keck PE Jr, et al. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum 2007;56:1336-44.
60. Sayar K, Aksu G, Ak I, Tosun M. Venlafaxine treatment of fibromyalgia. Ann Pharmacother 2003;37:1561-5.
61. Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004;50:2974-84.
62. Arnold LM, Rosen A, Pritchett YL, D'Souza DN, Goldstein DJ, Iyengar S, et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 2005;119:5-15.
63. Russell IJ, Mease PJ, Smith TR, Kajdasz DK, Wohlreich MM, Detke MJ, et al. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disoders: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain 2008;136:432-44.
64. Vitton O, Gendreau M, Gendreau J, Kranzler J, Rao SG. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia. Hum Psychopharmacol 2004;19(Suppl 1):S27-35.
65. Clauw DJ, Mease P, Palmer RH, Gendreau RM, Want Y. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-conrolled, multiple-dose clinical trial. Clin Ther 2008;30:1988-2004.
66. Mease PJ, Clauw DJ, Gendreau RM, Rao SG, Kranzler J, Chen W, et al. The efficacy and safety of minacipran in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial. J Rheumatol 2009;36:398-409.
67. Simpson DA. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Neuromuscul Dis 2001;3:53-62.
68. Goldenberg DL, Mayskiy M, Mossey CJ, Ruthazer R, Schmid C. A randomized, double-blind crossover trial of fl uoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996 ;39:1852-9.
69. Hauser W, Bernardy K, Uceyler N, Sommer C. Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis. JAMA 2009;301:198-209.
70. Bennett RM, Kamin M, Karim R, Rosenthal N. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Med 2003;114:537-45.
71. Busch AJ, Thille P, Barber KA, Schachter Cl, Bidonde J, Collacott BK. Best practice: E-Model - prescribing physical activity and exercise for individuals with fibromyalgia. Physiother Therory Pract 2008;24:151-66.
72. Janal MN. Pain sensitivity, exercise and stoicism. J R Soc Med 1996;89:376-381.
73. McCain GA, Bell DA, Mai FM, Halliday PD. A controlled study of the effects of a supervised cardiovascular fitness training program on manifestations of primary fibromyalgia. Arthritis Rheum 1988;31:1135-41.
74. Arnold LM. Biology and therapy of fibromylagia. New therapies in fibromyalgia. Arthritis Res Ther 2006:8:212.
75. Morley S, Eccleston C, Williams A. Systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy and behaviour therapy for chronic pain in adults, excluding headache. Pain 1999;80:1-13.
76. Williams DA. Psychological and behavioral therapies in fibromyalgia and related syndromes. Best Pract Res Clin Rheumatol 2003;17:649-65.
77. Hammond A, Freeman K. Community patient education and exercise for people with fibromyalgia: a parallel group randomized controlled trial. Clin Rehabil 2006;20:835-46.
78. Bennet RM. The rational management of fibromyalgia patients. Rheum Dis Clin North Am 2002;28:181-99.